期刊
FERTILITY AND STERILITY
卷 115, 期 4, 页码 831-839出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2021.01.016
关键词
SARS-CoV-2; gametes; embryos; in vitro fertilization; infertility care; ART laboratory
The COVID-19 pandemic has brought changes in societal interactions, necessitating protection against the SARS-CoV-2 virus; Assisted reproduction in this pandemic faces unique challenges, requiring thorough examination of practices, risk identification, and mitigation planning; Professional fertility societies have issued guidelines to ensure quality patient care, while ongoing updates help adapt infection control protocols amidst increasing knowledge of SARS-CoV-2.
The coronavirus disease 2019 pandemic has resulted in many changes in how we interact in society, requiring that we protect ourselves and others from an invisible, airborne enemy called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Until a vaccine is developed, and it reaches high levels of distribution, everyone must continue to be diligent to limit the viral spread. The practice of assisted reproduction during this pandemic presents unique challenges in addition to the risks identified in general clinical care. The established good tissue practices employed in laboratories are not designed to protect gametes and embryos from an airborne virus, particularly one that may be shed by an asymptomatic staff member. Armed with theoretical risks but lacking direct evidence, assisted-reproduction teams must examine every aspect of their practice, identify areas at a risk of exposure to SARS-CoV-2, and develop a mitigation plan. Several professional fertility societies have created guidelines for the best practices in patient care during the coronavirus disease 2019 pandemic. As we learn more about SARS-CoV-2, updates have been issued to help adapt infection-control and -prevention protocols. This review discusses what is currently known about SARS-CoV-2 infection risks in assisted reproductive centers and recommends the implementation of specific mitigation strategies. (C) 2021 by American Society for Reproductive Medicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据